EANS-Adhoc: Oxygen Biotherapeutics Reports Financial Results For Third Quarter FY2011
Contact: Ellen Corliss Vice President, Corporate Communications & Investor Relations Oxygen Biotherapeutics, Inc 2530 Meridian Pkwy, 3rd floor Durham, NC 27713 Direct Telephone: +1 919 855 2112 Direct Fax: +1 919 806 4417 Email: e.corliss@oxybiomed.com Branche: Biotechnology ISIN: US69207P2092 WKN: 10728277 Index: SSIRT Börsen: New York / Nasdaq SIX Swiss Exchange / ...